Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
PGNX > SEC Filings for PGNX > Form 8-K on 30-May-2014All Recent SEC Filings

Show all filings for PROGENICS PHARMACEUTICALS INC

Form 8-K for PROGENICS PHARMACEUTICALS INC


30-May-2014

Other Events, Financial Statements and Exhibits


Item 8.01. Other Events.

Progenics Pharmaceuticals, Inc. (PGNX) today announced it will present a poster reporting data from the company's phase 2 trial of its PSMA ADC anti-body drug conjugate product candidate at the American Society of Clinical Oncology in Chicago. The data update previously presented results from a study of the drug in 83 patients with metastatic castration-resistant prostate cancer whose disease had progressed despite treatment with at least one taxane-containing chemotherapy.
A copy of the company's press release is included in this Report as Exhibit 99.1.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

99.1 Press Release dated May 30, 2014.


  Add PGNX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for PGNX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.